Lucid Diagnostics (LUCD) Capital Expenditures (2021 - 2026)
Lucid Diagnostics filings provide 5 years of Capital Expenditures readings, the most recent being $51000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures fell 80.31% to $51000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $197000.0, a 33.45% decrease, with the full-year FY2025 number at $197000.0, down 33.45% from a year prior.
- Capital Expenditures hit $51000.0 in Q4 2025 for Lucid Diagnostics, up from $28000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.8 million in Q3 2022 to a low of $1000.0 in Q2 2021.
- Median Capital Expenditures over the past 5 years was $37000.0 (2024), compared with a mean of $280941.2.
- Biggest five-year swings in Capital Expenditures: skyrocketed 23500.0% in 2022 and later crashed 99.5% in 2023.
- Lucid Diagnostics' Capital Expenditures stood at $824000.0 in 2021, then soared by 241.75% to $2.8 million in 2022, then tumbled by 93.79% to $175000.0 in 2023, then skyrocketed by 48.0% to $259000.0 in 2024, then crashed by 80.31% to $51000.0 in 2025.
- The last three reported values for Capital Expenditures were $51000.0 (Q4 2025), $28000.0 (Q3 2025), and $25000.0 (Q2 2025) per Business Quant data.